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Abstract
Low vitamin B12 status is common in older people; however, its public health significance in terms of neurological manifestations remains
unclear. The present systematic review evaluated the association of vitamin B12 status with neurological function and clinically relevant
neurological outcomes in adults aged 50þ years. A systematic search of nine bibliographic databases (up to March 2013) identified
twelve published articles describing two longitudinal and ten cross-sectional analyses. The included study populations ranged in size
(n 28–2287) and mean/median age (range 65–81 years). Studies reported various neurological outcomes: nerve function; clinically
measured signs and symptoms of nerve function; self-reported neurological symptoms. Studies were assessed for risk of bias, and results
were synthesised qualitatively. Among the general population groups of older people, one longitudinal study reported no association, and
four of seven cross-sectional studies reported limited evidence of an association of vitamin B12 status with some, but not all, neurological
outcomes. Among groups with clinical and/or biochemical evidence of low vitamin B12 status, one longitudinal study reported an associ-
ation of vitamin B12 status with some, but not all, neurological outcomes and three cross-sectional analyses reported no association. Over-
all, there is limited evidence from observational studies to suggest an association of vitamin B12 status with neurological function in older
people. The heterogeneity and quality of the evidence base preclude more definitive conclusions, and further high-quality research is
needed to better inform understanding of public health significance in terms of neurological function of vitamin B12 status in older people.
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Ageing is associated with a decline in vitamin B12 status
(1,2),
and there is widespread evidence of low vitamin B12 status
in older people(1,3). In the UK, 5 % of adults aged 65–74
years and 10 % adults aged $75 years have low vitamin B12
levels (defined as vitamin B12 ,150 pmol/l) or metabolically
significant vitamin B12 deficiency (defined as vitamin B12
,200 pmol/l and homocysteine level .20mmol/l)(1). How-
ever, intakes of vitamin B12 in adults are mostly adequate
and in the most recent National Diet and Nutrition Survey of
the UK, only 1 % of adults aged 65–74 years and $75 years
had vitamin B12 intakes below the lower reference nutrient
intakes(4). Several factors relating to vitamin B12 absorption
may contribute to poor status in older people, including a
decrease in gastric acidity, the presence of atrophic gastritis,
compromised functional and structural integrity of vitamin
B12-binding proteins, and lack of liver vitamin B12 stores
(5).
Indeed, food-cobalamin malabsorption can account for up
to 60–70 % of confirmed cases of vitamin B12 deficiency in
older people(6).
The clinical manifestations of vitamin B12 deficiency can be
haematological, neurological or both(7); neurological symp-
toms can occur in the absence of anaemia in 20–30 % of
cases(8). Pathological investigations in vitamin B12 deficiency
reveal demyelination in the spinal cord, peripheral nerves
and/or the white matter of the brain(7) and an abnormal
increase in astrocytes in the brain due to damage to nearby
neurons(9). It has been proposed that the mechanism by
which vitamin B12 deficiency affects neurological function
involves impairment of vitamin B12-dependent enzyme
functions. Impaired function of methionine synthase leads to
elevated homocysteine levels, and impaired function of
L-methylmalonyl-CoA mutase leads to elevated methyl
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malonic acid concentrations, each resulting in impaired
methylation reactions and changes to fatty acid incorporation
in myelin(10,11). However, there is recent evidence to suggest
that mechanisms involving an imbalance in cytokines and
growth factors in the central nervous system may be import-
ant; it is not yet clear whether these findings can be extended
to the peripheral nervous system(12,13). Symptoms of periph-
eral neuropathy associated with vitamin B12 deficiency
commonly include symmetric paresthesias, numbness or gait
problems. Other neurological defects include impaired
vibration sense, impaired position and cutaneous sensation,
ataxia, and weakness(2,7). The relationship between vitamin
B12 status and cognitive function has been reviewed exten-
sively elsewhere(14–17).
The functional and public health significance of low vitamin
B12 status in older people is currently unclear. In the clinical
setting, impaired neurological function is a known marker of
frank vitamin B12 deficiency. However, whether neurological
impairment is associated with low vitamin B12 status at a
population level is unknown. To date, the epidemiological
evidence of the association of vitamin B12 status with neuro-
logical function has not been systematically reviewed. The
present systematic review aims to evaluate the association of
low vitamin B12 status with neurological outcomes relevant
to central and peripheral nerve function in older people. It
is hoped that findings will inform public health and nutrition
guidance to be provided on the functional relevance of
vitamin B12 status in later life.
Experimental methods
Methods of analysis and inclusion criteria were specified in
advance and documented (protocol available on request
from the authors). The present systematic review is reported
according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses guidelines.
Search strategy
A systematic search of bibliographic databases was conducted
on 28 March 2013. All observational study designs assessing
the association of vitamin B12 status with neurological out-
comes in older people were included except case reports/
series, narrative reviews, editorials and conference reports.
Included subject groups were older people with a median
or mean age $50 years and could be resident in institutions
or the community. Studies of subject groups with known
existing medical conditions affecting neurological function
(including alcoholism, HIV, diabetes-associated neuropathy
or motor neurone disease), vitamin B12 status (including
bariatric surgery) or metabolites of vitamin B12 (including
renal insufficiency) were excluded. Included exposures were
serum/plasma vitamin B12, transcobalamin (a binding protein
for vitamin B12), holotranscobalamin (the form of vitamin B12
able to cross into the cells), methyl malonic acid (a metabolite
of vitamin B12) and dietary vitamin B12 (but not multiple
vitamin and mineral supplements). Included outcomes were
peripheral sensory or motor nerve function/conduction,
central motor conduction; peripheral neuropathy; clinical
signs and symptoms of neurological (but not cognitive) func-
tion (somatosensory disorders, knee and ankle jerk/reflexes,
joint, position and vibration sense, ataxia, and propriocep-
tion); and self-reported neurological (but not cognitive)
symptoms (pain, altered sensation, unsteadiness, prickly
feelings, weakness, numbness, and difficulty walking).
Search terms were developed for nine medical and public
health databases using both MeSH terms and text terms
where possible: MEDLINE (1946 to March week 3, 2013; see
online Supplementary data); Global Health (1910 to February
2013); EMBASE (1974 to 27 March 2013); PsycInfo (1806 to
March week 3, 2013); CINAHL Plus (1937 to March 2013);
Cochrane Library (inception to March 2013); ClinicalTrials.gov
(inception to March 2013); Scopus (1823 to 28 March 2013);
TRIP database (inception to March 2013). Papers not trans-
lated into English and grey literature were excluded. The
reference lists of included studies were hand-searched for
any further articles relevant to the review.
Assessment of eligibility of studies and data extraction
Articles were assessed for inclusion first using titles and
abstracts, and then full copies of articles considered poten-
tially relevant were reviewed. Eligibility assessment was
carried out by two independent reviewers (L. M. M. and
A. D. D.). Disagreements were resolved by discussion
between the two reviewers; if no agreement could be reached,
a third party was available to arbitrate.
Once the included list of papers was finalised, one reviewer
(L. M. M.) extracted data and assessed risk of bias in each
paper; another author (A. D. D.) checked the extracted data.
Disagreements about extracted data were resolved by discus-
sion between the two reviewers. Forms for data extraction and
assessment of risk of bias were developed based on checklists
developed by the Scottish Intercollegiate Guidelines Network
(SIGN)(18). These checklists relate to study characteristics that
are likely to have a significant influence on the validity of the
reported results. Data were extracted into forms, defined accord-
ing to the SIGN guidance, and risk of bias was assessed for
each study based on the research question, selection of
subjects (including age and population type), exposure and
outcome assessment, comparisons made and effect sizes/
summary measures, follow-up time (where appropriate),
adjustment for confounders, and statistical analysis. Each
of these study characteristics was judged as ‘well
covered’, ‘adequately addressed’, ‘poorly addressed’, ‘not
addressed’, ‘not reported’ or ‘not applicable’. Neurological
outcomes were categorised as measures of nerve function
(nerve conduction studies), clinically assessed signs and
symptoms of peripheral neuropathy or self-reported symp-
toms. The latter outcomes were judged to be ‘poorly
addressed’ because self-reported symptoms are subjective
and open to bias from the subject. Studies mostly achieving
‘well covered’ or ‘adequately addressed’ were judged to
have a low risk of bias; others were judged to have a risk of
bias. The assessment of risk of bias was completed at the
study level (see online Supplementary data) and was used in
the qualitative synthesis of results to place greater emphasis
Lisa M. Miles et al.504
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on studies of higher quality. No study was excluded based on
the assessment of risk of bias.
All study characteristics, effect sizes and summary measures
were extracted from studies and tabulated to allow compari-
son. Care was taken to identify cases where multiple articles
were published from the same study. When a report referred
to data on relevant exposures and outcomes that could be
included in the review, or when potentially relevant
exposures or outcomes were not reported, efforts were
made to contact the author for further information. The
authors of eight articles were contacted by email and four
authors responded. Of these, two authors provided further
information that has been included in the results and two
authors did not provide any additional information.
Resultswere synthesised in a qualitativemanner. Studieswere
reviewed to assess whether findings varied according to the
study population (general population or subjects with evidence
of vitamin B12 deficiency), category of neurological outcome,
definition of low vitamin B12 status, adjustment for confounders
or age. Combining data by meta-analysis was not possible as a
result of the heterogeneity of the available evidence. To identify
risk of bias from selective reporting, for each included article,
the reviewers checked whether all exposures and outcomes
measured were also reported in the results section. No formal
testing of publication bias was possible.
Results
Study selection
The search identified 982 records. Of these, 835 were
excluded as not relevant following title and abstract review.
Full-text articles for the remaining 147 records were sought,
though one was not retrievable(19). Furthermore, two
additional articles identified through hand-searching did not
meet the inclusion criteria. A total of 148 full-text articles
were examined in detail; 136 did not meet the pre-defined
inclusion criteria. Full-text articles were most commonly
excluded because they were not original reports from
observational studies, neurological outcomes focused only
on cognition, and/or the mean/median age of the study
subjects was #50 years. Finally, twelve articles were included
in the review (Fig. 1).
Study characteristics
Twelve reports from ten studies (two longitudinal and ten
cross-sectional analyses) met the inclusion criteria. Of these,
six were conducted in Europe(20–27), with the remaining
studies conducted in the USA(28), Asia(29,30) and Australia(31).
Of the European articles, three were from Denmark with over-
lapping samples of participants from the same study(20–22).
There was heterogeneity in the types of population from
which subjects were drawn; eight articles(23,24,26–31) were
based on general population groups of older people, though
two of these recruited from hospitals (see online Supplemen-
tary Table S1), and four articles(20–22,25) (from two studies)
were based on subjects with clinical and/or biochemical evi-
dence of low vitamin B12 status (see online Supplementary
Table S2). The studies included in the review involved partici-
pants aged 65–81 years. There was heterogeneity between
studies in the definition of vitamin B12 status and in the neuro-
logical outcomes reported. Most studies reported on more
than one category of neurological outcome. Five studies
measured electrophysiological measures of nerve function,
1648 records were identified through database search
982 records were screened for inclusion based on the title/abstract
147 full-text articles were identified  to assess for eligibility
Two articles were identified
through hand-searching
One article was not
retrievable
148 full-text articles were assessed for eligibility
Twelve articles were included in the qualitative analysis
982 unique records were identified after removing duplicates
835 records were excluded
136 full-text articles were
excluded
Fig. 1. Study selection process for the systematic review of the association of vitamin B12 status with neurological function in older people.
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ten studies reported clinically measured signs and symptoms
of neuropathy, and eight studies collected self-reported neuro-
logical symptoms.
Studies based on subjects from the general population
One longitudinal(23) and seven cross-sectional(24,26–31) ana-
lyses were based on general population groups of older
people (see online Supplementary Table S1). One longitudinal
study(23) with a follow-up of 3 and 6 years and low risk of bias
provided no evidence of an association of vitamin B12 status
or change in vitamin B12 status with electrophysiological
measures of nerve function or peripheral neuropathy. One
cross-sectional analysis(28) with a low risk of bias suggested
an association of low vitamin B12 status with some, but not
all, electrophysiological measures of nerve function. One
small cross-sectional analysis(29) with an identified risk of
bias found no association of vitamin B12 status and electro-
physiological measures of nerve function. Five further
cross-sectional studies with low(24,26) or identified(27,30,31)
risk of bias reported clinically measured signs and symptoms
of neuropathy and self-reported neurological symptoms, and
provided mixed results. Three analyses(24,27,30) identified a
statistically significant association of vitamin B12 status with
some, but not all, clinical signs of neuropathy or self-reported
symptoms, the remaining two cross-sectional studies(26,31)
reported no associations with any outcome. Four studies
based on subjects from the general population adjusted for
at least age and sex in the analyses; there was no clear pattern
in findings according to adjustment for confounders.
Studies based on subjects with low vitamin B12 status
One longitudinal analysis(22) (mean follow-up1·0–3·9 years) and
three cross-sectional analyses(20,21,25) were based on subjects
with clinical and/or biochemical evidence of low vitamin B12
status (see online Supplementary Table S2). One small cross-
sectional study(25) with an identified risk of bias found no
association of vitamin B12 status with electrophysiological
measures of nerve function (no adjustment for confounders).
The remaining three articles from one Danish study had
identified risk of bias, reported neurological signs and symptoms
as outcomes, and adjusted for age and sex. The cross-sectional
analyses(20,21) from the Danish study did not identify any
association of vitamin B12 status with neurological symptoms;
the results from the longitudinal analysis were mixed.
The next two paragraphs refer to all the results, not just
studies based on subjects with low vitamin B12 status.
Overall, there was no clear pattern in findings according to
ageof subjects or adjustment for confounders.Of thefive studies
that reported positive associations between vitamin B12 status
and neurological function, three used composite definitions of
low vitamin B12 status involving plasma/serum vitamin B12
plus elevated methyl malonic acid or homocysteine levels.
The exercise to identify selective reporting bias showed
that two cross-sectional studies(27,30) did not report results for
all neurological outcomes measured. In addition, one longitudi-
nal analysis of participants with low vitamin B12 status
(22)
measured dietary vitamin B12 intake, but did not report any
results for associations with neurological outcomes. Overall,
this suggests that selective reporting of outcomes within some
studiesmayhave affected risk of bias in the cumulative evidence.
Discussion
Overall, there is limited evidence from observational studies of
older people living in the general population to suggest an
association of vitamin B12 status with neurological function.
Few studies are available, and the majority are cross-sectional
in design, limiting any causality inference. The single longi-
tudinal analysis using a general population group found no
association between vitamin B12 status and nerve conduc-
tion(23). The limited evidence for an association comes from
four of seven cross-sectional analyses(24,27,28,30) that identified
positive associations of vitamin B12 and neurological function
for some, but not all, outcomes. There is a similar lack of
evidence of an association from studies of subjects with low
vitamin B12 status. None of the three cross-sectional analyses
(from two studies)(20,21,25) reported any association of vitamin
B12 status with neurological function, and in the single longi-
tudinal analysis(22), results were mixed.
This is the first systematic review investigating the associ-
ation of vitamin B12 status with neurological function in
older people. Systematic reviews specifically aim to minimise
bias resulting from partial identification, evaluation and
reporting of the available evidence base. The search strategy
used in the present systematic review was comprehensive,
study eligibility assessment was carried out by two indepen-
dent reviewers, and each included study was assessed for
risk of bias. The literature search was limited to English
language and published literature, and may have missed
relevant studies published in other languages and in the
grey literature such as conference proceedings. The hetero-
geneity of the available evidence precluded the conduct of
meta-analysis.
Studies assessed a heterogeneous range of neurological
outcomes. The most sensitive and objective measures of
neurological function relevant to vitamin B12 status are electro-
physiological measures of nerve conduction. However, many
of the included studies were reliant only on self-reported
symptoms and/or signs and symptoms of neuropathy, which
are open to bias from the subject or clinician. It is possible
that outcome ascertainment is a limitation of the review.
There was also clinical heterogeneity in study populations
(general population or vitamin B12 deficient) and in how
low vitamin B12 status was defined. Debate continues about
the most appropriate method for assessing vitamin B12 status
in terms of the thresholds used to define low status or deficiency
and the use of various biomarkers. Recent developments
suggest the need to measure vitamin B12 status using both a
biomarker of circulating vitamin B12 and a functional biomarker
such as methyl malonic acid or homocysteine(32). This approach
of using a composite measure was used in three of the included
studies, all of which reported some positive associations. Close
attention to the most appropriate definition of low vitamin B12
status is warranted in future research.
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Several studies identified in the review were subject to risk
of bias. Some studies did not provide adequate information
about response rates when recruiting to the study or infor-
mation about non-respondents, and five studies did not
adjust for confounders (age and sex) in the analyses. In
addition, selective reporting of outcomes within some studies
may have affected risk of bias in the cumulative evidence.
Overall, the lack of longitudinal studies, heterogeneity of the
evidence, and risk of bias made it difficult to reach any firm
conclusions.
Overall, there is limited evidence from observational studies
to suggest an association of vitamin B12 status with neurologi-
cal function in older people. Further high-quality research is
needed to better inform understanding of the clinical signifi-
cance (in terms of neurological function) of vitamin B12
status in older people. Well-designed observational studies
that comply with the latest recommendations on measuring
vitamin B12 status
(32) and measure neurological function by
nerve conduction would be most valuable. It is also important
that any studies measuring associations also identify and
adjust appropriately for confounders. Such evidence is
required in order to provide robust conclusions on whether
measures of vitamin B12 status are clinically relevant markers
of central and peripheral nerve function in older people.
Supplementary material
To view supplementary material for this article, please visit
http://dx.doi.org/10.1017/S0007114515002226
Acknowledgements
The authors acknowledge funding from the Food Standards
Agency (NO5072) and the Department of Health that sup-
ported in part the preparation of the manuscript. The research
received no other grant from any funding agency, commercial
or not-for-profit sectors.
The authors’ contributions are as follows: L. M. M. devel-
oped the protocol for the present review, selected the articles
for inclusion in the review, completed the data extraction,
interpreted the results of the review, and wrote the manu-
script; A. D. D. critically reviewed the protocol for the
review, selected the articles for inclusion in the review,
checked the data extraction, and critically reviewed the manu-
script; K. M. reviewed the search strategy and critically
reviewed the manuscript; R. C. critically reviewed the
manuscript.
The authors declare that they have no conflicts of interest.
References
1. Clarke R, Grimley Evans J, Schneede J, et al. (2004) Vitamin
B12 and folate deficiency in later life. Age Ageing 33, 34–41.
2. Baik HW & Russell RM (1999) Vitamin B12 deficiency in the
elderly. Annu Rev Nutr 19, 357–377.
3. Finch S, Doyle W & Lowe C (1998) The National Diet and
Nutrition Survey: People Aged 65 Years and Over. Vol 1:
Report of the Diet and Nutrition Survey. London: The
Stationery Office.
4. Bates B, Lennox A, Prentice A, et al. (2014) National Diet
and Nutrition Survey. Headline Results from Years 1, 2, 3
and 4 (Combined) of the Rolling Programme (2008/2009–
2011/12). London: Public Health England.
5. Institute of Medicine (1998) Dietary Reference Intakes for
Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin
B12, Pantothenic Acid, Biotin, and Choline. Washington,
DC: National Academy of Sciences.
6. Andre`s E, Loukili NH, Noel E, et al. (2004) Vitamin B12
(cobalamin) deficiency in elderly patients. CMAJ 171,
251–259.
7. Stabler SP (2013) Vitamin B12 deficiency. N Engl J Med 368,
149–160.
8. Lindenbaum J, Healton EB, Savage DG, et al. (1988) Neurop-
sychiatric disorders caused by cobalamin deficiency in the
absence of anemia or macrocytosis. New England J Med
318, 1720–1728.
9. Scalabrino G (2009) The multi-faceted basis of vitamin B12
(cobalamin) neurotrophism in adult central nervous
system: lessons learned from its deficiency. Prog Neurobiol
88, 203–220.
10. Reynolds E (2006) Vitamin B12, folic acid, and the nervous
system. Lancet Neurol 5, 949–960.
11. Selhub J, Troen A & Rosenberg IH (2010) B vitamins and the
aging brain. Nutr Rev 68, Suppl. 2, s112–s118.
12. Scalabrino G (2005) Cobalamin (vitamin B12) in subacute
combined degeneration and beyond: traditional interpret-
ations and novel theories. Exp Neurol 192, 463–479.
13. Scalabrino G & Peracchi M (2006) New insights into the
pathophysiology of cobalamin deficiency. Trends Mol Med
12, 247–254.
14. Clarke R, Birks J, Nexo E, et al. (2007) Low vitamin B-12
status and risk of cognitive decline in older adults. Am J
Clin Nutr 86, 1384–1391.
15. O’Leary F, Allman-Farinelli M & Samman S (2012) Vitamin
B12 status, cognitive decline and dementia: a systematic
review of prospective cohort studies. Br J Nutr 108,
1948–1961.
16. Dangour AD, Whitehouse PJ, Rafferty K, et al. (2010)
B-vitamins and fatty acids in the prevention and treatment
of Alzheimer’s disease and dementia: a systematic review.
J Alzheimers Dis 22, 205–224.
17. Malouf R & Areosa Sastre A (2003) Vitamin B12 for cognition.
The Cochrane Database of Systematic Reviews 2003, issue 3,
CD004326.
18. Scottish Intercollegiate Guidelines Network (2011) SIGN 50.
A Guideline Developer’s Handbook. Edinburgh: Scottish
Intercollegiate Guidelines Network.
19. Bozdemir H, Sarica Y, Kocak R, et al. (1994) Conduction of
peripheral and central nerve fiber improve following B12
administration in megaloblastic anemia. Ann Med Sci 3,
75–81.
20. Hvas AM & Nexo E (2005) Holotranscobalamin – a first
choice assay for diagnosing early vitamin B12 deficiency?
J Intern Med 257, 289–298.
21. Hvas AM, Ellegaard J & Nexo E (2001) Vitamin B12 treatment
normalizes metabolic markers but has limited clinical effect:
a randomized placebo-controlled study. Clin Chem 47,
1396–1404.
22. Hvas AM, Ellegaard J & Nexo E (2001) Increased plasma
methylmalonic acid level does not predict clinical manifes-
tations of vitamin B12 deficiency. Arch Intern Med 161,
1534–1541.
23. Leishear K, Ferrucci L, Lauretani F, et al. (2012) Vitamin B12
and homocysteine levels and 6-year change in peripheral
Vitamin B12 status and neurological function 507
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114515002226
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 24 Feb 2018 at 19:40:02, subject to the Cambridge Core terms of use, available at
nerve function and neurological signs. J Gerontol A: Biol Sci
Med Sci 67, 537–543.
24. Hin H, Clarke R, Sherliker P, et al. (2006) Clinical
relevance of low serum vitamin B12 concentrations in
older people: the Banbury B12 study. Age Ageing 35, 416–422.
25. Turgut B, Turgut N, Akpinar S, et al. (2006) Dorsal
sural nerve conduction study in vitamin B12 deficiency with
megaloblastic anemia. J Peripher Nerv Syst 11, 247–252.
26. Bjo¨rkegren K & Sva¨rdsudd K (2003) Reported symptoms
and clinical findings in relation to serum cobalamin, folate,
methylmalonic acid and total homocysteine among elderly
Swedes: a population-based study. J Intern Med 254,
343–352.
27. Gadoth N, Figlin E, Chetrit A, et al. (2006) The neurology
of cobalamin deficiency in an elderly population in Israel.
J Neurol 253, 45–50.
28. Leishear K, Boudreau RM, Studenski SA, et al. (2012)
Relationship between vitamin B12 and sensory and motor
peripheral nerve function in older adults. J Am Geriatr Soc
60, 1057–1063.
29. Sucharita S, Thomas T, Antony B, et al. (2012) Vitamin B12
supplementation improves heart rate variability in healthy
elderly Indian subjects. Auton Neurosci 168, 66–71.
30. Wang YH, Yan F, Zhang WB, et al. (2009) An investigation of
vitamin B12 deficiency in elderly inpatients in neurology
department. Neurosci Bull 25, 209–215.
31. Metz J, Bell AH, Flicker L, et al. (1996) The significance of
subnormal serum vitamin B12 concentration in older people:
a case control study. J Am Geriatr Soc 44, 1355–1361.
32. Yetley EA1, Pfeiffer CM, Phinney KW, et al. (2011)
Biomarkers of vitamin B-12 status in NHANES: a roundtable
summary. Am J Clin Nutr 94, 313S–321S.
Lisa M. Miles et al.508
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114515002226
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 24 Feb 2018 at 19:40:02, subject to the Cambridge Core terms of use, available at
